Quarterly report pursuant to Section 13 or 15(d)

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.5.0.2
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Dec. 31, 2015
Dec. 31, 2014
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]            
Research and Development Expense $ 560,514 $ 354,471 $ 2,139,671 $ 1,146,113    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) 8,090,190   8,090,190   7,780,190  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in Shares) 6,745,099   6,745,099      
Registration Payment Arrangement, Accrual Carrying Value $ 0   $ 0   $ 0 $ 55,620
Employee Stock Option [Member]            
NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) 8,090,190   8,090,190   7,780,190  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in Shares) 6,745,099   6,745,099   5,613,501